AI Article Synopsis
- The study analyzed short-term disability claims for respiratory diseases submitted to the Mexican Social Security Institute in 2020, totaling 1,631,587 claims from 19.1 million insured workers.
- The cumulative incidence of these claims was 8.5%, which is 3.6 times higher compared to data from January 2015 to December 2019.
- Workers in sectors like healthcare, social assistance, self-service, and retail were found to be particularly affected by these respiratory disease claims.
Article Abstract
We examined respiratory disease short-term disability claims submitted to the Mexican Social Security Institute during 2020. A total of 1,631,587 claims were submitted by 19.1 million insured workers. Cumulative incidence (8.5%) was 3.6 times higher than that for January 2015‒December-2019. Workers in healthcare, social assistance, self-service, and retail stores were disproportionately affected.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714224 | PMC |
| http://dx.doi.org/10.3201/eid2801.211357 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A methodological research for development and psychometric properties of a new Measure to Assess Health Literate Organization (MAHLO-76) in hospital settings.
BMC Health Serv Res
December 2024
Environmental and Occupational Hazards Control Research Center, Research Institute for Health Sciences and Environment, Shahid Beheshti University of Medical Sciences, Tabnak Ave., Daneshjou Blvd., Velenjak, P.O. Box 19835-35511, Tehran, I.R, Iran.
Background: Toward delivering appropriately safe, high quality and effective health care, healthcare organization should be health literate. This paper presents the development and psychometrics of an instrument for assessing the attributes of a health literate hospital which is called MAHLO-76 (Measure to Assess Health Literate Organization) here by authors.
Methods: The current study is methodological research which is involved two phases of tool development and psychometric evaluation.
COVID-19: A threat to the respiratory system.
Int J Immunopathol Pharmacol
December 2024
Office of Research, Innovation and Commercialization (ORIC), University of Sargodha, Sargodha, Punjab, Pakistan.
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causes acute coronavirus disease-19 (COVID-19) that has emerged on a pandemic level. Coronaviruses are well-known to have a negative impact on the lungs and cardiovascular system. SARS-CoV-2 induces a cytokine storm that primarily targets the lungs, causing widespread clinical disorders, including COVID-19.
View Article and Find Full Text PDFMycobacterium tuberculosis (Mtb) remains a leading infectious disease responsible for millions of deaths. RNA sequencing is a rapidly growing technique and a powerful approach to understanding host and pathogen cross-talks via transcriptional responses. However, its application is limited due to the high costs involved.
View Article and Find Full Text PDFAre noradrenergics combined with antimuscarinics the future pharmacologic treatment for obstructive sleep apnea? A systematic review and meta-analysis of randomized controlled trials.
Sleep Breath
December 2024
Faculty of Medicine, Assiut University, Assiut, Egypt.
Purpose: Noradrenergics and antimuscarinics have been proposed as future pharmacotherapy for obstructive sleep apnea (OSA). However, the available randomized controlled trials (RCTs) showed heterogeneous results regarding the safety and efficacy of the combined regimen in OSA. Therefore, we performed this meta-analysis from the published RCTs to clarify this conflicting evidence.
View Article and Find Full Text PDFAuthor Correction: π-HuB: the proteomic navigator of the human body.
Nature
December 2024
State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!